Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torkell Ellingsen

Showing results (91-100 of 112) with videos related to

Pageof 12
Sort By:
BMJ Open|April 22, 2016
Multifactorial intervention to prevent cardiovascular disease in patients with early rheumatoid arthritis: protocol for a multicentre randomised controlled trialAnnemarie Lyng Svensson, Robin Christensen, Frederik Persson, et al.
Annals of the Rheumatic Diseases|May 7, 2010
Radiographic progression and remission rates in early rheumatoid arthritis - MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trialMerete L Hetland, Kristian Stengaard-Pedersen, Peter Junker, et al.
Annals of the Rheumatic Diseases|February 26, 2013
Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trialKim Hørslev-Petersen, Merete Lund Hetland, Peter Junker, et al.
Annals of the Rheumatic Diseases|June 15, 2017
Magnetic resonance imaging assessed inflammation in the wrist is associated with patient-reported physical impairment, global assessment of disease activity and pain in early rheumatoid arthritis: longitudinal results from two randomised controlled trialsDaniel Glinatsi, Joshua F Baker, Merete L Hetland, et al.
Annals of the Rheumatic Diseases|October 15, 2020
Towards consensus in defining and handling contextual factors within rheumatology trials: an initial qualitative study from an OMERACT working groupSabrina Mai Nielsen, Marianne Uggen Rasmussen, Maarten Boers, et al.
Scandinavian Journal of Immunology|July 8, 2024
Effects of smoking on clinical treatment outcomes amongst patients with chronic inflammatory diseases initiating biologics: secondary analyses of the prospective BELIEVE cohort studyMaja Graves Rosenkilde Larsen, Silja Hvid Overgaard, Sofie Ronja Petersen, et al.
The Journal of Rheumatology|May 4, 2010
Uncoupling of collagen II metabolism in newly diagnosed, untreated rheumatoid arthritis is linked to inflammation and antibodies against cyclic citrullinated peptidesAnne Friesgaard Christensen, Kim Hørslev-Petersen, Stephan Christgau, et al.
Arthritis Research & Therapy|March 10, 2010
Circulating surfactant protein -D is low and correlates negatively with systemic inflammation in early, untreated rheumatoid arthritisAnne Friesgaard Christensen, Grith Lykke Sørensen, Kim Hørslev-Petersen, et al.
Annals of the Rheumatic Diseases|January 14, 2014
A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis: results from the OPERA randomised controlled trialMette Bjørndal Axelsen, Iris Eshed, Kim Hørslev-Petersen, et al.
Scandinavian Journal of Immunology|June 23, 2025
Impact of Obesity on Treatment Response in Patients With Chronic Inflammatory Disease Receiving Biologic Therapy: Secondary Analysis of the Prospective Multicentre BELIEVE Cohort StudyKlara Riber Eggers, Karen Mai Møllegaard, Laura Gregersen, et al.
Pageof 12

Showing results (91-100 of 112) with videos related to

Sort By:
Pageof 12
BMJ Open|April 22, 2016
Multifactorial intervention to prevent cardiovascular disease in patients with early rheumatoid arthritis: protocol for a multicentre randomised controlled trialAnnemarie Lyng Svensson, Robin Christensen, Frederik Persson, et al.
Annals of the Rheumatic Diseases|May 7, 2010
Radiographic progression and remission rates in early rheumatoid arthritis - MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trialMerete L Hetland, Kristian Stengaard-Pedersen, Peter Junker, et al.
Annals of the Rheumatic Diseases|February 26, 2013
Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trialKim Hørslev-Petersen, Merete Lund Hetland, Peter Junker, et al.
Annals of the Rheumatic Diseases|June 15, 2017
Magnetic resonance imaging assessed inflammation in the wrist is associated with patient-reported physical impairment, global assessment of disease activity and pain in early rheumatoid arthritis: longitudinal results from two randomised controlled trialsDaniel Glinatsi, Joshua F Baker, Merete L Hetland, et al.
Annals of the Rheumatic Diseases|October 15, 2020
Towards consensus in defining and handling contextual factors within rheumatology trials: an initial qualitative study from an OMERACT working groupSabrina Mai Nielsen, Marianne Uggen Rasmussen, Maarten Boers, et al.
Scandinavian Journal of Immunology|July 8, 2024
Effects of smoking on clinical treatment outcomes amongst patients with chronic inflammatory diseases initiating biologics: secondary analyses of the prospective BELIEVE cohort studyMaja Graves Rosenkilde Larsen, Silja Hvid Overgaard, Sofie Ronja Petersen, et al.
The Journal of Rheumatology|May 4, 2010
Uncoupling of collagen II metabolism in newly diagnosed, untreated rheumatoid arthritis is linked to inflammation and antibodies against cyclic citrullinated peptidesAnne Friesgaard Christensen, Kim Hørslev-Petersen, Stephan Christgau, et al.
Arthritis Research & Therapy|March 10, 2010
Circulating surfactant protein -D is low and correlates negatively with systemic inflammation in early, untreated rheumatoid arthritisAnne Friesgaard Christensen, Grith Lykke Sørensen, Kim Hørslev-Petersen, et al.
Annals of the Rheumatic Diseases|January 14, 2014
A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis: results from the OPERA randomised controlled trialMette Bjørndal Axelsen, Iris Eshed, Kim Hørslev-Petersen, et al.
Scandinavian Journal of Immunology|June 23, 2025
Impact of Obesity on Treatment Response in Patients With Chronic Inflammatory Disease Receiving Biologic Therapy: Secondary Analysis of the Prospective Multicentre BELIEVE Cohort StudyKlara Riber Eggers, Karen Mai Møllegaard, Laura Gregersen, et al.
Pageof 12